French results of the ARESC Study: Clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy-Reference-Cited by-同舟云学术

French results of the ARESC Study: Clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy

Published:2012-02 Issue:2 Volume:42 Page:66-75
ISSN:0399-077X
Container-title:Médecine et Maladies Infectieuses
language:en
Short-container-title:Médecine et Maladies Infectieuses

Author:

Neuzillet Yann,Naber Kurt G.,Schito Giancarlo,Gualco Laura,Botto Henry

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference34 articles.

1. Epidemiology of urinary tract infections: incidence, morbidity and economic costs;Foxman;Am J Med,2002

2. Detection, prevention and management of UTIs;Kunin,1997

3. Urinary tract infections in diabetes;Nicolle;Curr Opin Infect Dis,2005

4. Urinary tract infection in pregnancy;MacLean;Br J Urol,1997

5. Recurrent urinary tract infections in postmenopausal women;Raz;Clin Infect Dis,2000

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the knowledge and skills of medical workers providing primary health care in the field of acute cystitis diagnosis and treatment in accordance with the modern clinical recommendations;Russian Journal of Preventive Medicine;2024

2. Ganoderma Lucidum - A Potential Medicinal Mushroom Against MDR Isolates from The Secondary Infections of Covid-19;International Journal of Life Science and Pharma Research;2023-03-01

3. First Detection of Klebsiella pneumoniae Isolate Co-Harboring Fosfomycin Resistance Gene fosA3 and blactx-m Among Gram Negative Urine Isolates in a Turkish Hospital;Microbial Drug Resistance;2021-12-01

4. Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS);BMC Infectious Diseases;2021-06-14

5. Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints;Médecine et Maladies Infectieuses;2020-10